{
  "disease_name": "Lung cancer",
  "synonyms": [
    "Lung carcinoma",
    "Bronchogenic carcinoma"
  ],
  "summary": "Lung cancer is a malignant tumor originating from lung tissue, usually the lining of the air passages. It is primarily caused by smoking and exposure to carcinogens, and it remains the leading cause of cancer deaths globally.",
  "causes": [
    "Tobacco smoking",
    "Secondhand smoke exposure",
    "Radon gas exposure",
    "Asbestos exposure",
    "Air pollution",
    "Occupational exposure to arsenic, chromium, nickel, or beryllium",
    "Ionizing radiation",
    "Genetic mutations activating oncogenes or deactivating tumor suppressor genes (e.g., EGFR, KRAS, TP53)"
  ],
  "risk_factors": [
    "Smoking",
    "Secondhand smoke",
    "Exposure to radon",
    "Exposure to asbestos or heavy metals",
    "Air pollution",
    "Family history of lung cancer",
    "Chronic obstructive pulmonary disease (COPD)",
    "Older age",
    "Male sex"
  ],
  "symptoms": [
    "Persistent cough",
    "Coughing up blood",
    "Chest pain",
    "Shortness of breath",
    "Wheezing",
    "Hoarseness",
    "Loss of appetite",
    "Weight loss",
    "Fatigue",
    "Swelling of face or neck"
  ],
  "diagnosis": [
    "Chest X-ray",
    "CT scan",
    "PET scan",
    "Biopsy (needle, bronchoscopy, or surgical)",
    "Sputum cytology",
    "MRI for brain metastasis detection",
    "Genetic testing for EGFR, ALK, ROS1, or KRAS mutations"
  ],
  "treatments": [
    "Surgery (lobectomy, wedge resection, or pneumonectomy)",
    "Radiation therapy",
    "Chemotherapy",
    "Targeted therapy (EGFR inhibitors, ALK inhibitors, MET inhibitors, RET inhibitors, BRAF inhibitors)",
    "Immunotherapy (PD-1 or PD-L1 inhibitors such as pembrolizumab, nivolumab, atezolizumab)",
    "Palliative care",
    "Laser therapy or cryotherapy for airway obstruction"
  ],
  "related_genes": [
    "EGFR",
    "ALK",
    "KRAS",
    "BRAF",
    "MET",
    "ROS1",
    "RET",
    "TP53",
    "RB1",
    "PIK3CA"
  ],
  "subtypes": [
    {
      "name": "Non-small cell lung cancer (NSCLC)",
      "typical_patients": "Adults, especially smokers or ex-smokers aged 60–80",
      "five_year_survival": "25% (average across stages)",
      "common_treatments": [
        "Surgery",
        "Chemotherapy",
        "Targeted therapy",
        "Immunotherapy"
      ]
    },
    {
      "name": "Small cell lung cancer (SCLC)",
      "typical_patients": "Heavy smokers, typically older adults",
      "five_year_survival": "10–15%",
      "common_treatments": [
        "Chemotherapy",
        "Radiation therapy",
        "Immunotherapy"
      ]
    },
    {
      "name": "Adenocarcinoma",
      "typical_patients": "Most common in non-smokers and women",
      "five_year_survival": "≈40% (localized stage)",
      "common_treatments": [
        "Surgery",
        "Targeted therapy (EGFR, ALK inhibitors)"
      ]
    },
    {
      "name": "Squamous cell carcinoma",
      "typical_patients": "Smokers, usually men",
      "five_year_survival": "≈30% (localized stage)",
      "common_treatments": [
        "Surgery",
        "Chemotherapy",
        "Radiation therapy"
      ]
    },
    {
      "name": "Large cell carcinoma",
      "typical_patients": "Adults, often smokers",
      "five_year_survival": "≈15–20% (varies by stage)",
      "common_treatments": [
        "Chemotherapy",
        "Radiation therapy"
      ]
    }
  ],
  "epidemiology": {
    "global_cases_2015": 2200000,
    "global_deaths_2015": 1800000,
    "most_common_in": "Smokers and individuals exposed to environmental carcinogens",
    "five_year_survival_rate": "19% (overall, varies by stage and sex)"
  },
  "relationships": [
    {
      "source": "Lung cancer",
      "relation": "has_symptom",
      "target": "Persistent cough"
    },
    {
      "source": "Lung cancer",
      "relation": "has_symptom",
      "target": "Coughing up blood"
    },
    {
      "source": "Lung cancer",
      "relation": "has_symptom",
      "target": "Chest pain"
    },
    {
      "source": "Lung cancer",
      "relation": "has_symptom",
      "target": "Shortness of breath"
    },
    {
      "source": "Lung cancer",
      "relation": "has_risk_factor",
      "target": "Smoking"
    },
    {
      "source": "Lung cancer",
      "relation": "has_risk_factor",
      "target": "Secondhand smoke"
    },
    {
      "source": "Lung cancer",
      "relation": "has_risk_factor",
      "target": "Radon exposure"
    },
    {
      "source": "Lung cancer",
      "relation": "has_risk_factor",
      "target": "Asbestos exposure"
    },
    {
      "source": "Lung cancer",
      "relation": "has_cause",
      "target": "Tobacco smoking"
    },
    {
      "source": "Lung cancer",
      "relation": "has_cause",
      "target": "Genetic mutations (EGFR, KRAS, TP53)"
    },
    {
      "source": "Lung cancer",
      "relation": "associated_gene",
      "target": "EGFR"
    },
    {
      "source": "Lung cancer",
      "relation": "associated_gene",
      "target": "ALK"
    },
    {
      "source": "Lung cancer",
      "relation": "associated_gene",
      "target": "KRAS"
    },
    {
      "source": "Lung cancer",
      "relation": "treated_with",
      "target": "Chemotherapy"
    },
    {
      "source": "Lung cancer",
      "relation": "treated_with",
      "target": "Radiation therapy"
    },
    {
      "source": "Lung cancer",
      "relation": "treated_with",
      "target": "Targeted therapy"
    },
    {
      "source": "Lung cancer",
      "relation": "treated_with",
      "target": "Immunotherapy"
    },
    {
      "source": "Non-small cell lung cancer",
      "relation": "subtype_of",
      "target": "Lung cancer"
    },
    {
      "source": "Small cell lung cancer",
      "relation": "subtype_of",
      "target": "Lung cancer"
    },
    {
      "source": "Adenocarcinoma",
      "relation": "subtype_of",
      "target": "Non-small cell lung cancer"
    },
    {
      "source": "Squamous cell carcinoma",
      "relation": "subtype_of",
      "target": "Non-small cell lung cancer"
    },
    {
      "source": "Large cell carcinoma",
      "relation": "subtype_of",
      "target": "Non-small cell lung cancer"
    },
    {
      "source": "Non-small cell lung cancer",
      "relation": "associated_gene",
      "target": "EGFR"
    },
    {
      "source": "Small cell lung cancer",
      "relation": "associated_gene",
      "target": "RB1"
    },
    {
      "source": "Non-small cell lung cancer",
      "relation": "treated_with",
      "target": "Osimertinib"
    },
    {
      "source": "Small cell lung cancer",
      "relation": "treated_with",
      "target": "Cisplatin and Etoposide"
    },
    {
      "source": "Adenocarcinoma",
      "relation": "treated_with",
      "target": "EGFR inhibitors"
    }
  ]
}